Zotila Pharmaceuticals Limited
Founded in 2017 and headquartered in Delhi, India.
2017 | Delhi (India) | Active
Zotila Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 21.95%
- Profit Growth 31.03%
- Ebitda -15.38%
- Net Worth -0.42%
- Total Assets -0.18%
About Zotila Pharmaceuticals
Zotila Pharmaceuticals Limited (ZPL) is a Public Limited Indian Non-Government Company incorporated in India on 11 July 2017 (Seven years and nine months 22 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Santosh Kushawaha, Pooja Kushawaha, Gaurav Pandey, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999DL2017PLC320468
- Company No.
320468
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Jul 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Business Services
Zotila Pharmaceuticals Limited
Explore comprehensive data for Zotila Pharmaceuticals Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Zotila Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Kushawaha  | Director | 11-Jul-2017 | Current |
| Pooja Kushawaha | Director | 11-Jul-2017 | Current |
| Gaurav Pandey | Director | 11-Jul-2017 | Current |
| Deepak Pandey | Director | 11-Jul-2017 | Current |
Financial Performance of Zotila Pharmaceuticals.
Zotila Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.95% increase. The company also saw a substantial improvement in profitability, with a 31.03% increase in profit. The company's net worth dipped by a decrease of 0.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zotila Pharmaceuticals?
Unlock access to Zotila Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rds Corporate Services Private LimitedSantosh Kushawaha is a mutual person
A F Enterprises LimitedSantosh Kushawaha is a mutual person
- Snp Infosolutions Limited Liability Part Nership
Santosh Kushawaha and Pooja Kushawaha are mutual person
- Kyra Landscapes Limited
Santosh Kushawaha is a mutual person
- Kamal Skilled Games (Opc) Private Limited
Santosh Kushawaha is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zotila Pharmaceuticals?
Unlock and access historical data on people associated with Zotila Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zotila Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zotila Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Zotila Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Zotila Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Zotila Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Director Appointment
Santosh Kumar Kushawaha was appointed as a Director was appointed as a Director on 11 Jul 2017 & has been associated with this company since 7 years 9 months .
- Director Appointment
Pooja Kushawaha was appointed as a Director was appointed as a Director on 11 Jul 2017 & has been associated with this company since 7 years 9 months .
- Director Appointment
Gaurav Kumar Pandey was appointed as a Director was appointed as a Director on 11 Jul 2017 & has been associated with this company since 7 years 9 months .
- Director Appointment
Deepak Kumar Pandey was appointed as a Director was appointed as a Director on 11 Jul 2017 & has been associated with this company since 7 years 9 months .
Frequently asked questions
What is the Incorporation or founding date of Zotila Pharmaceuticals Limited?
Zotila Pharmaceuticals Limited was incorporated on 11 Jul 2017.
What is authorized share capital and paid-up capital of Zotila Pharmaceuticals Limited?
The authorized share capital of Zotila Pharmaceuticals Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Zotila Pharmaceuticals Limited?
Currently 4 directors are associated with Zotila Pharmaceuticals Limited.
- Santosh Kumar Kushawaha
- Pooja Kushawaha
- Gaurav Kumar Pandey
- Deepak Kumar Pandey
What is the registered address of Zotila Pharmaceuticals Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Zotila Pharmaceuticals Limited is Dsm-438, Dlf Towers Shivaji Marg India, New Delhi, 110015.
What is the corporate identification number (CIN) and company number of Zotila Pharmaceuticals Limited?
The corporate identification number (CIN) of Zotila Pharmaceuticals Limited is U74999DL2017PLC320468 and the company number is 320468 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Zotila Pharmaceuticals Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Zotila Pharmaceuticals Limited has risen by 21.95%.
What change has been observed in the net worth of Zotila Pharmaceuticals Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Zotila Pharmaceuticals Limited has experienced an downturn of -0.42%.
When was the last Balance Sheet of Zotila Pharmaceuticals Limited filed with the ROC?
The most recent Balance Sheet for Zotila Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records